Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme

NCT00704288 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
222
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Exelixis